BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27680485)

  • 21. Response to treatment in a prospective national infantile spasms cohort.
    Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
    Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infantile spasms: therapy and outcome.
    Riikonen R
    J Child Neurol; 2004 Jun; 19(6):401-4. PubMed ID: 15446386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Update of the medical treatment of West syndrome.
    Verrotti A; Manco R; Coppola GG; Mingione S; Chiarelli F; Iannetti P
    Minerva Pediatr; 2007 Jun; 59(3):249-53. PubMed ID: 17519870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Favourable prognostic factors with infantile spasms.
    Riikonen RS
    Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Treatments for Infantile Spasms: A Systematic Review.
    Song JM; Hahn J; Kim SH; Chang MJ
    Clin Neuropharmacol; 2017; 40(2):63-84. PubMed ID: 28288483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vigabatrin monotherapy for infantile spasms.
    Gaily E
    Expert Rev Neurother; 2012 Mar; 12(3):275-86. PubMed ID: 22364326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Proposals for the treatment of children with West's syndrome].
    Herranz JL; Argumosa A
    Rev Neurol; 2000 Sep 16-30; 31(6):578-83. PubMed ID: 11055064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
    Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
    Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling new therapies for infantile spasms.
    Chudomelova L; Scantlebury MH; Raffo E; Coppola A; Betancourth D; Galanopoulou AS
    Epilepsia; 2010 Jul; 51 Suppl 3(Suppl 3):27-33. PubMed ID: 20618396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
    Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
    Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature.
    Bhalla S; Skjei K
    Epilepsia; 2020 Oct; 61(10):e159-e164. PubMed ID: 32944947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of infantile spasms.
    Haines ST; Casto DT
    Ann Pharmacother; 1994 Jun; 28(6):779-91. PubMed ID: 7919570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infantile spasms and cytomegalovirus infection: antiviral and antiepileptic treatment.
    Dunin-Wasowicz D; Kasprzyk-Obara J; Jurkiewicz E; Kapusta M; Milewska-Bobula B
    Dev Med Child Neurol; 2007 Sep; 49(9):684-92. PubMed ID: 17718825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced visual function associated with infantile spasms in children on vigabatrin therapy.
    Hammoudi DS; Lee SS; Madison A; Mirabella G; Buncic JR; Logan WJ; Snead OC; Westall CA
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):514-20. PubMed ID: 15671276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter long-term follow-up of children with idiopathic West syndrome: ACTH versus vigabatrin.
    Cohen-Sadan S; Kramer U; Ben-Zeev B; Lahat E; Sahar E; Nevo Y; Eidlitz T; Zeharia A; Kivity S; Goldberg-Stern H
    Eur J Neurol; 2009 Apr; 16(4):482-7. PubMed ID: 19348622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A European perspective—comments on "Infantile spasms: a U.S. consensus report".
    Riikonen R
    Epilepsia; 2010 Oct; 51(10):2215-6; author reply 2221. PubMed ID: 21069906
    [No Abstract]   [Full Text] [Related]  

  • 37. ACTH versus vigabatrin therapy in infantile spasms: a retrospective study.
    Cossette P; Riviello JJ; Carmant L
    Neurology; 1999 May; 52(8):1691-4. PubMed ID: 10331702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.
    Lux AL; Edwards SW; Hancock E; Johnson AL; Kennedy CR; Newton RW; O'Callaghan FJ; Verity CM; Osborne JP;
    Lancet Neurol; 2005 Nov; 4(11):712-7. PubMed ID: 16239177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome).
    Jaseja H
    Med Hypotheses; 2006; 67(4):721-4. PubMed ID: 16781824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy.
    Zafeiriou DI; Kontopoulos EE; Tsikoulas IG
    Brain Dev; 1996; 18(6):450-2. PubMed ID: 8980841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.